1. Articles from Bram de Haas

    1-1 of 1
    1. Why ValueAct Pounced On Citigroup (NYSE:C)

      Why ValueAct Pounced On Citigroup (NYSE:C)

      ValueAct, a successful activist fund, has built a $1.2 billion stake in Citigroup ( C ). According to the WSJ it suggested Citigroup could boost its buyback plan from $40 to $50 billion. With a market cap of $185 billion that's a large percentage of stock to take out. Buyback programs of this relative size are rare. ValueAct seems to favor Citigroup for its old-fashioned treasury management for global businesses which is making it an important global money center bank...

      Read Full Article
    1-1 of 1
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics in the News

    1. (4 articles) Chairman
    2. (4 articles) CEO
    3. (3 articles) Management
    4. (3 articles) stock options
    5. (2 articles) Executive Compensation
    6. (2 articles) Carl Icahn
    7. (2 articles) NYSE
    8. (2 articles) risk
    9. (2 articles) crisis
    10. (2 articles) Bank
    11. (1 articles) Citigroup
    12. (1 articles) ValueAct Capital
    13. (1 articles) NYSE
    14. (1 articles) Dodd-Frank
    15. (1 articles) KKR
    16. (1 articles) Management
    17. (1 articles) Buyback
    18. (1 articles) stock options
    19. (1 articles) Bank
    20. (1 articles) stake
  3. Popular Articles

  4. Picture Gallery

    Why ValueAct Pounced On Citigroup (NYSE:C) Benchmark Electronics (BHE) Appoints Merilee Raines To The Board Of Directors M&T Bank Corp. (MTB) Elects Kevin Pearson to Board of Directors Lloyds Banking: Faces Shareholder Revolt as CEO's Pay is 95 Times That of Average Worker Despite 34% Cut, AstraZeneca Shareholders Still Don't Like CEO Soriot's £9.4M Pay Corvex and Icahn to Mull Making a Bid for Energen Arca Capital to Work With Icahn to Oppose AmTrust Privatization Plan Aratana Therapeutics (PETX) Appoints Craig Barbarosh and Lowell Robinson to Board in ... Acacia Research Corporation Board of Directors Issues Letter to Stockholders AxoGen (AXGN) Names Karen Zaderej as Board Chairman World's 50 Greatest Leaders Deciphera Pharmaceuticals Expands Board with the Election of Mr. Steven L. Hoerter as a Director